NFC
PHAS

Northeast Financial Consultants’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Northeast Financial Consultants’s Portfolio PHAS Stock Details PHAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-37,760
Closed -$7K – 363
2022
Q3 		$7K Hold
37,760
– – ﹤0.01% 333
2022
Q2 		$23K Hold
37,760
– – ﹤0.01% 329
2022
Q1 		$50K Hold
37,760
– – ﹤0.01% 385
2021
Q4 		$99K Buy
+37,760
New +$99K 0.01% 348